
Resmed Inc (NYSE:RMD) reported better-than-expected earnings for the second quarter on Thursday.
The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.46 per share. The company reported quarterly sales of $1.348 billion which beat the analyst consensus estimate of $1.321 billion.